Karen A. Gelmon
BC Cancer Agency(CA)University of British Columbia(CA)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics
Most-Cited Works
- → Palbociclib and Letrozole in Advanced Breast Cancer(2016)2,879 cited
- → Metastatic Behavior of Breast Cancer Subtypes(2010)2,247 cited
- → 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)(2016)2,058 cited
- → The clonal and mutational evolution spectrum of primary triple-negative breast cancers(2012)2,008 cited
- → Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer(2021)1,581 cited
- → 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial(2007)1,506 cited